Journals / Gazi Medical Journal / 2013 / Cilt: 24 - Sayı: 3

Radiation therapy in metastatic breast cancer

Metastatik meme kanserlerinde radyoterapi

Pages
102–107
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Radiation therapy which can be applied with different fractionation schedules and dose concepts, provides effective symptom palliation on patients with bone or brain metastasis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Metastasis develops in 25-40% of breast cancer patients beyond their disease process.
📊
Key Findings & Data:Locally treatment of oligometastatic breast cancer is, radical treatment including surgery and/or radiation therapy, if the patient has good performance status.
💡
Conclusion & Impact:Radiation therapy which can be applied with different fractionation schedules and dose concepts, provides effective symptom palliation on patients with bone or brain metastasis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Metastasis develops in 25-40% of breast cancer patients beyond their disease process. The prognosis of metastatic breast cancer differs depending on various factors. The evaluation of the patient and the decision of the treatment must be individualized. Locally treatment of oligometastatic breast cancer is, radical treatment including surgery and/or radiation therapy, if the patient has good performance status. Radiation therapy which can be applied with different fractionation schedules and dose concepts, provides effective symptom palliation on patients with bone or brain metastasis.

Özet

Meme kanserli hastaların %25-40ında hastalık süreci boyunca metastazgelişmektedir. Metastatik meme kanserinde prognoz pek çok faktöre bağlıolarak değişmektedir. Her hasta için bireysel değerlendirme ve tedavi kararıönemlidir. Oligometastatik olarak nitelendirilen, soliter veya birkaç tanemetastatik lezyonu olan genç yaşta ve performansı iyi olan metastatik memekanserli hastaların lokal (meme ve lenfatik) tedavisinde günümüz içinönerilen tedavi cerrahi ve/veya radyoterapidir. Kemik metastazları ya dabeyin metastazları olan hastalarda, farklı fraksinasyon şemaları ileuygulanabilen lokal radyoterapi ile oldukça etkin semptom palyasyonusağlanabilmektedir.

🔖

Cite This Article

ÜLGER, Ş. (2022). Radiation therapy in metastatic breast cancer. Gazi Medical Journal, Cilt: 24 - Sayı: 3, 102–107. https://ajindex.com/articles/650786

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Maughan KL, Lutterbie MA, Ham SP.Treatment of Breast Cancer.American Family Physician 2010;81:1339-46
  2. Guarneri V, Franco P. The curability of breast cancer and the treatment of advanced disease. ConteEuropean Journal of Nuclear Medicine and Molecular Imaging. 2004;31:149-61
  3. Pagani O, Senkus E, Wood W, Colleoni M, Cufer T, Kyriakides S, et al. International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured? 2010;102:456-63
  4. Giordano SH, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN. Is breast cancer survival improving? Cancer 2004;100:44–52
  5. Hanrahan EO, Broglio KR, Buzdar AU, Theriault RL, Valero V, Cristofanilli M, et al. Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors. Cancer 2005;104:1158–71
  6. Nieto Y, Cagnoni PJ, Shpall EJ, Matthes S, Barón A, Jones RB, et al. Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease. Clin Cancer Res 1999;5:1731–7
  7. Clavel M. Management of breast cancer with bone metastases. Bone 1991;12:11-2
  8. Vassiliou V, Kalogeropoulou C, Christopoulos C, Solomou E, Leotsinides M, Kardamakis D. Combination ibandronate and radiotherapy for the treatment of bone metastases: clinical evaluation and radiologic assessment. Int J Radiat Oncol Biol Phys 2007;67:264-72. 9 Wu JS, Wong R, Johnston M, Bezjak A, Whelan T; Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group. Meta-analysis of dose- fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 2003;55:594-605
  9. Halperin EC, Perez CA, Brady LW. Principles and Practice of Radiation Oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2008:1986- 1999
  10. Saarto T, Janes R, Tenhunen M, Kouri M. Palliative radiotherapy in the treatment of skeletal metastases. Eur J Pain 2002;6:323–30
  11. Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy – a systematic review of randomised trials. Clin Oncol (R Coll Radiol) 2003; 15:345-52
  12. Delozier T. Radiotherapie palliative des metastases osseuses; J Eur Radiother 1984;2: 99-104
  13. Koswig S, Buchali A, Böhmer D, Schlenger L, Budach V. Palliative radiotherapy of bone metastases. A retro